These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35012325)

  • 1. Epigenetic Regulation of
    Corbin LJ; White SJ; Taylor AE; Williams CM; Taylor K; van den Bosch MT; Teasdale JE; Jones M; Bond M; Harper MT; Falk L; Groom A; Hazell GGJ; Paternoster L; Munafò MR; Nordestgaard BG; Tybjærg-Hansen A; Bojesen SE; Relton C; Min JL; Davey Smith G; Mumford AD; Poole AW; Timpson NJ
    Circ Res; 2022 Feb; 130(3):384-400. PubMed ID: 35012325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to welding fumes is associated with hypomethylation of the F2RL3 gene: a cardiovascular disease marker.
    Hossain MB; Li H; Hedmer M; Tinnerberg H; Albin M; Broberg K
    Occup Environ Med; 2015 Dec; 72(12):845-51. PubMed ID: 26395445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y
    Whitley MJ; Henke DM; Ghazi A; Nieman M; Stoller M; Simon LM; Chen E; Vesci J; Holinstat M; McKenzie SE; Shaw CA; Edelstein LC; Bray PF
    J Thromb Haemost; 2018 Dec; 16(12):2501-2514. PubMed ID: 30347494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F2RL3 methylation in blood DNA is a strong predictor of mortality.
    Zhang Y; Yang R; Burwinkel B; Breitling LP; Holleczek B; Schöttker B; Brenner H
    Int J Epidemiol; 2014 Aug; 43(4):1215-25. PubMed ID: 24510982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
    Norman JE; Cunningham MR; Jones ML; Walker ME; Westbury SK; Sessions RB; Mundell SJ; Mumford AD
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):952-60. PubMed ID: 26966273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
    Lee DH; Hwang SH; Lim MK; Oh JK; Song DY; Yun EH; Park EY
    PLoS One; 2017; 12(4):e0176783. PubMed ID: 28453567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease.
    Breitling LP; Salzmann K; Rothenbacher D; Burwinkel B; Brenner H
    Eur Heart J; 2012 Nov; 33(22):2841-8. PubMed ID: 22511653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.
    Muehlschlegel JD; Perry TE; Liu KY; Fox AA; Smith SA; Lichtner P; Collard CD; Shernan SK; Hartwig JH; Body SC; Hoffmeister KM
    Am J Hematol; 2012 Feb; 87(2):161-6. PubMed ID: 22228373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F2RL3 methylation as a biomarker of current and lifetime smoking exposures.
    Zhang Y; Yang R; Burwinkel B; Breitling LP; Brenner H
    Environ Health Perspect; 2014 Feb; 122(2):131-7. PubMed ID: 24273234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F2RL3 methylation, lung cancer incidence and mortality.
    Zhang Y; Schöttker B; Ordóñez-Mena J; Holleczek B; Yang R; Burwinkel B; Butterbach K; Brenner H
    Int J Cancer; 2015 Oct; 137(7):1739-48. PubMed ID: 25821117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
    Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
    Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.
    Edelstein LC; Simon LM; Lindsay CR; Kong X; Teruel-Montoya R; Tourdot BE; Chen ES; Ma L; Coughlin S; Nieman M; Holinstat M; Shaw CA; Bray PF
    Blood; 2014 Nov; 124(23):3450-8. PubMed ID: 25293779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking-associated DNA methylation markers predict lung cancer incidence.
    Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
    Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes.
    Su D; Wang X; Campbell MR; Porter DK; Pittman GS; Bennett BD; Wan M; Englert NA; Crowl CL; Gimple RN; Adamski KN; Huang Z; Murphy SK; Bell DA
    PLoS One; 2016; 11(12):e0166486. PubMed ID: 27935972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
    Rigg RA; Healy LD; Chu TT; Ngo ATP; Mitrugno A; Zilberman-Rudenko J; Aslan JE; Hinds MT; Vecchiarelli LD; Morgan TK; Gruber A; Temple KJ; Lindsley CW; Duvernay MT; Hamm HE; McCarty OJT
    Platelets; 2019; 30(1):126-135. PubMed ID: 30560697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the epigenetic signatures in subjects with coronary artery disease.
    Indumathi B; Oruganti SS; Naushad SM; Kutala VK
    Mol Biol Rep; 2020 Sep; 47(9):6693-6703. PubMed ID: 32803503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of hypertension and F2RL3 gene methylation with Prognosis of coronary heart disease.
    Gao BF; Shen ZC; Bian WS; Wu SX; Kang ZX; Gao Y
    J Biol Regul Homeost Agents; 2018; 32(6):1539-1544. PubMed ID: 30574762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoking differently influences cell types of the innate and adaptive immune system-indications from CpG site methylation.
    Bauer M; Fink B; Thürmann L; Eszlinger M; Herberth G; Lehmann I
    Clin Epigenetics; 2015; 7():83. PubMed ID: 27493699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.
    Achilles A; Mohring A; Dannenberg L; Grandoch M; Hohlfeld T; Fischer JW; Levkau B; Kelm M; Zeus T; Polzin A
    J Thromb Haemost; 2017 Mar; 15(3):473-476. PubMed ID: 27992120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
    Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
    J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.